A malaria vaccine developed by Oxford University and Serum Institute of India (SII) has been recommended for large-scale use by the World Health Organization (WHO). The R21/Matrix-M—only the second malaria jab—has shown up to 75% efficacy.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Mint Primer","authorlink":""},"src":"https:\/\/traffic.megaphone.fm\/HTMEDIALTD7956652069.mp3?updated=1739282685","thumb":{"src":"https:\/\/megaphone.imgix.net\/podcasts\/72ca81d2-e880-11ef-97b0-073248652955\/image\/3d1b4a456cdedd3056a09578dfd2be76.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format%2Ccompress&s=tellyfonic"},"title":"Malaria Gets its Second Vax: Why it\u2019s Momentous","link":"javascript:;","id":"item-205838443"}]
